<DOC>
	<DOC>NCT02143843</DOC>
	<brief_summary>The purpose of this study is to evaluate safety and comfort of the ForSight VISION5 product when used for up to 13 months.</brief_summary>
	<brief_title>An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma, Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<criteria>1. Completed FSV5002 study. 2. Written informed consent prior to any study procedure. 3. Willingness to comply with the visit schedule. 1. Participation in an investigational drug or device study other than FSV5002 within the past 6 months or anticipated participation during the study period. 2. Subjects who will require contact lens use during the study period. 3. Any condition or situation (such as uncontrolled systemic disease) that, in the Investigator's opinion, might confound the results of the study, may put the subject at significant risk or might interfere with the subject's ability to participate in the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>